HSE bucks global trend and reverses fall in cervical cancer vaccine uptake
The latest vaccine figures will come as a relief to doctors and other healthcare professionals who had expressed serious concern about successive drops in recent years
The HSE has reversed the decline in uptake of the cervical cancer vaccine, making Ireland the first country to successfully fight back against campaigners who eroded public confidence in the vaccine.
Provisional figures show uptake of the vaccine increased to 61 per cent this year - up from 50 per cent last year.
The rise is regarded as significant as it has taken public health authorities years to recover from previous scares such ...